TrialNeuro-oncology2010

Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastoma.

Doo-Sik Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.